NSCLC - Non Small Cell Lung Cancer Now Closed
KEYNOTE-598 / MK-3475-598 - Hosted By elie
Save
Bookmark
Print
Sponsor Name | |
Tumor Site | NSCLC - Non Small Cell Lung Cancer |
Disease Stage | Stage IV |
Clinical Status | Advanced Disease 1st Line |
Phase | Phase III |
Intervention / Treatment | Pembrolizumab + Ipilimumab vs Ipilumumab + Placebo |
Research Site | Montreal, QC, St. Mary's Hospital |
Investigator | Dr Adrian Langleben |
Telephone Number | +1 (514) 345-3511 |
Study Start Date | October 5, 2017 |
Study End Date | February 22, 2024 |
Trial Status | Recruitment Complete |